Showing 1 - 20 results of 468 for search '"Регуляторные исследования и экспертиза лекарственных средств"', query time: 0.45s Refine Results
  1. 1

    ASPECTS OF MEDICINES QUALITY EVALUATION BY ELECTRICAL SENSING ZONE METHOD by E. S. Novik, A. V. Dorenskaya, N. A. Borisova, O. V. Gunar

    Published 2018-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  2. 2

    Current Requirements for and Approaches to Dosing in Animal Studies by A. V. Rybakova, M. N. Makarova, A. E. Kukharenko, A. S. Vichare, F. R. Rueffer

    Published 2018-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  3. 3

    Natalia Valeryevna Pyatigorskaya (on the 55th Anniversary) by article Editorial

    Published 2020-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  4. 4

    EXPERIMENTAL TESTING OF THE MODIFIED METHOD OF INTRAVITREAL INJECTION IN THE RABBIT EYE by A. V. Kalatanova, A. E. Katelnikova, M. N. Makarova, V. G. Makarov

    Published 2018-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  5. 5

    Control of the Purity of 93% Oxygen Obtained from the Air by Pressure Swing Adsorption by R. A. Enikeeva, Yu. V. Miroshnichenko, V. L. Bagirova, O. A. Popova

    Published 2022-10-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  6. 6

    Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis by S. V. Khodko, M. N. Makarova, V. G. Makarov, S. S. Salynov, N. V. Rodionova

    Published 2021-10-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  7. 7

    Development of the method of trifluoroacetates determination in glatiramer acetate pharmaceutical substance by<sup>19</sup>F NMR spectroscopy by S. V. Moiseev, V. I. Krylov, N. E. Kuz’Mina, V. A. Yashkir, V. A. Merkulov

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  8. 8

    Alternative method for determining impurities in antimicrobial medicines by S. I. Kuleshova, T. I. Pshenichnykh, E. P. Simonova

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  9. 9

    Marketing Authorisation Based on Incomplete Clinical Data: International Experience and Prospects by D. V. Goryachev, N. E. Uvarova, G. V. Shukshina

    Published 2020-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  10. 10

    Problems of Establishing Limits for Arsenic Content in Brown Algae and Brown Algae-Containing Medicinal Products by V. M. Shchukin, A. A. Erina, E. A. Lisman, O. A. Vaganova

    Published 2019-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  11. 11
  12. 12

    Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza by A. I. Gubenko, G. V. Shukshina, A. I. Muravieva, N. E. Uvarova

    Published 2023-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  13. 13

    Pharmacokinetic (Bioavailability) Studies of Magnesium Preparations by N. N. Eremenko, E. V. Shikh, N. E. Uvarova

    Published 2023-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  14. 14

    Russian regulatory system for clinical trials is consistent with international approaches by Yu. N. Linkova

    Published 2023-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  15. 15

    Interchangeability of glibenclamide-containing drugs by G. I. Gorodetskaya, E. V. Shikh, M. V. Zhuravleva, S. Yu. Serebrova, E. A. Sokova, O. V. Muslimova, T. V. Aleksandrova, I. A. Mazerkina, S. G. Rudnev

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  16. 16

    Analysis of the provisions of national and EAEU legislation regulating pharmaceuticals before and after 1 January 2026 by A. G. Zaremba, E. M. Rychikhina

    Published 2023-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  17. 17

    Retraction of the article: Mironov A.N., Sakaeva I.V., Dudchenko V.V., Korneeva L.V., Yavorsky A.N. International experience in drug names assessment: european medicines agency by article Editorial

    Published 2022-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  18. 18

    Validation of pharmaceutical information systems: computer software and personal computers by K. A. Koschechkin, E. V. Gladkaya, Ya. Yu. Kondratieva

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  19. 19

    Recommendations on Describing the Requirements for Microbiological Quality and Sterility of Medicinal Products by O. V. Gunar

    Published 2022-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  20. 20

    EFFICACY AND SAFETY OF ANTIEPILEPTIC DRUGS DURING PREGNANCY: PHARMACOGENETIC ASPECTS by E. A. Sоkоvа, V. V. Arkhipov, R. A. Chilova, O. A. Demidova, G. F. Proklova, T. V. Pikuza

    Published 2018-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article